Skip to main content
. 2023 Oct 10;18(3):225–248. doi: 10.5114/pg.2023.131998
The mode of endoscopic surveillance in patients with atrophic gastritis and intestinal metaplasia depends on the location of the lesions (body and/or antrum) and the following risk factors: family history of gastric cancer, persistent H. pylori infection, incomplete intestinal metaplasia and a diagnosis of autoimmune gastritis.
Quality of evidence: moderate. Recommendation: strong.